Nuwellis Stock Analysis
NUWE Stock | USD 14.80 0.96 6.09% |
Nuwellis is overvalued with Real Value of 13.6 and Hype Value of 14.8. The main objective of Nuwellis stock analysis is to determine its intrinsic value, which is an estimate of what Nuwellis is worth, separate from its market price. There are two main types of Nuwellis' stock analysis: fundamental analysis and technical analysis.
The Nuwellis stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nuwellis' ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuwellis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. Nuwellis Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 630.42. Nuwellis last dividend was issued on the 19th of October 2020. The entity had 1:42 split on the 7th of July 2025. Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Nuwellis operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 70 people. To find out more about Nuwellis contact Nestor Jaramillo at 952 345 4200 or learn more at https://www.nuwellis.com.Nuwellis Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nuwellis' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nuwellis or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nuwellis had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 8.74 M. Net Loss for the year was (11.16 M) with profit before overhead, payroll, taxes, and interest of 5.7 M. | |
Nuwellis currently holds about 12.05 M in cash with (9.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38. | |
Nuwellis has a poor financial position based on the latest SEC disclosures | |
Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
Nuwellis Upcoming and Recent Events
27th of February 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Nuwellis Thematic Classifications
In addition to having Nuwellis stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Medical EquipmentUSA Equities from Medical Equipment industry as classified by Fama & French |
Nuwellis Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 102.93 M.Nuwellis Profitablity
The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.61) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.61.Technical Drivers
As of the 20th of July, Nuwellis secures the Mean Deviation of 8.97, downside deviation of 11.68, and Risk Adjusted Performance of 0.0101. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuwellis, as well as the relationship between them. Please verify Nuwellis jensen alpha and downside variance to decide if Nuwellis is priced some-what accurately, providing market reflects its recent price of 14.8 per share. Given that Nuwellis has jensen alpha of (0.24), we recommend you to check Nuwellis's last-minute market performance to make sure the company can sustain itself at a future point.Nuwellis Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Nuwellis for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Nuwellis short-term fluctuations and highlight longer-term trends or cycles.
Nuwellis Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuwellis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuwellis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuwellis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nuwellis Outstanding Bonds
Nuwellis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nuwellis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nuwellis bonds can be classified according to their maturity, which is the date when Nuwellis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
OCINV 67 16 MAR 33 Corp BondUS67116NAA72 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Nuwellis Predictive Daily Indicators
Nuwellis intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nuwellis stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nuwellis Forecast Models
Nuwellis' time-series forecasting models are one of many Nuwellis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nuwellis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nuwellis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuwellis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuwellis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nuwellis. By using and applying Nuwellis Stock analysis, traders can create a robust methodology for identifying Nuwellis entry and exit points for their positions.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Nuwellis operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 70 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nuwellis to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
Complementary Tools for Nuwellis Stock analysis
When running Nuwellis' price analysis, check to measure Nuwellis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuwellis is operating at the current time. Most of Nuwellis' value examination focuses on studying past and present price action to predict the probability of Nuwellis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuwellis' price. Additionally, you may evaluate how the addition of Nuwellis to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |